Author:
Andreopoulou Eleni,Vigoda Ivette S.,Valero Vicente,Hershman Dawn L.,Raptis George,Vahdat Linda T.,Han Hyo S.,Wright John J.,Pellegrino Christine M.,Cristofanilli Massimo,Alvarez Ricardo H.,Fehn Karen,Fineberg Susan,Sparano Joseph A.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Rochlitz CF, Scott GK, Dodson JM et al (1989) Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Cancer Res 49:357–360
2. Thor A, Ohuchi N, Hand PH et al (1986) ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest 55:603–615
3. Smith CA, Pollice AA, Gu LP et al (2000) Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Clin Cancer Res 6:112–126
4. Bunone G, Briand PA, Miksicek RJ et al (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174–2183
5. Kato S, Masuhiro Y, Watanabe M et al (2000) Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways. Genes Cells 5:593–601
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献